A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects

Trial Profile

A Multi-Centre, Single-Blind Study to Assess the Safety of Cat-PAD in Cat Allergic Paediatric Subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs Cat SPIRE (Primary)
  • Indications Asthma; Hypersensitivity; Rhinoconjunctivitis
  • Focus Adverse reactions
  • Sponsors Circassia
  • Most Recent Events

    • 06 Mar 2017 Results assessing the efficacy, safety and tolerability of Cat-PAD in children, presented at the 2017 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 07 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 12 Aug 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top